Literature DB >> 27959610

Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.

Craig E Gordon1, Swapna Vantzelfde1, Jean M Francis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27959610     DOI： 10.1056/NEJMc1609483

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Hypernatremia.

Authors:  Qi Qian
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 8.237

2.  Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.

Authors:  Soma Jobbagy; Dario A Vitturi; Sonia R Salvatore; Maria F Pires; Pascal Rowart; David R Emlet; Mark Ross; Scott Hahn; Claudette St Croix; Stacy G Wendell; Arohan R Subramanya; Adam C Straub; Roderick J Tan; Francisco J Schopfer
Journal:  JCI Insight       Date:  2020-01-16

3.  Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report.

Authors:  Ricardo A Macau; Tiago Nunes da Silva; Joana Rego Silva; Ana Gonçalves Ferreira; Pedro Bravo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.